Vanderbilt-Ingram Cancer Center, Henry-Joyce Cancer Clinic — Nashville, Tennessee

Vanderbilt-Ingram Cancer Center, Henry-Joyce Cancer Clinic is a clinical research site located in Nashville, Tennessee, United States.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Vanderbilt-Ingram Cancer Center, Henry-Joyce Cancer Clinic has participated in 1 clinical trials.

Therapeutic areas: Relapsed Multiple Myeloma, End-stage Renal Disease.

Sponsors: Amgen.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Vanderbilt-Ingram Cancer Center, Henry-Joyce Cancer Clinic?

Vanderbilt-Ingram Cancer Center, Henry-Joyce Cancer Clinic has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Vanderbilt-Ingram Cancer Center, Henry-Joyce Cancer Clinic conducted?

Vanderbilt-Ingram Cancer Center, Henry-Joyce Cancer Clinic has 1 clinical trials on record. Their work covers Relapsed Multiple Myeloma, End-stage Renal Disease.

Is Vanderbilt-Ingram Cancer Center, Henry-Joyce Cancer Clinic accredited by Crixeo Health?

Vanderbilt-Ingram Cancer Center, Henry-Joyce Cancer Clinic has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Vanderbilt-Ingram Cancer Center, Henry-Joyce Cancer Clinic?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.